Gong Kan
Gong Kan — Chief Physician — Urology — Peking University First Hospital
Specialties
1. Diagnosis and treatment of complex urinary system tumors. (1) Individualized, standardized, and full-process precise diagnosis and treatment of prostate cancer (Especially skilled in Da Vinci robotic radical prostatectomy, individualized precision treatment for prostate cancer patients, etc.). (2) Comprehensive diagnosis and treatment of complex and difficult kidney cancer (sporadic/hereditary kidney cancer diagnosis and treatment) (Robotic radical nephrectomy, partial nephrectomy, targeted drug therapy for advanced kidney cancer, standardized diagnosis and treatment for hereditary kidney cancer [VHL syndrome, BHD syndrome, etc.]) (3) Bladder cancer, renal pelvis/ureteral cancer, adrenal tumors, etc. (Transurethral resection of bladder tumors + bladder-preserving comprehensive treatment, robotic radical cystectomy and urinary diversion, robotic radical surgery for renal pelvis cancer and ureteral cancer, adrenal tumor resection, etc.) 2. Minimally invasive surgery and drug treatment for complex and difficult benign prostatic hyperplasia.
Professional Experience
Professor of Urology at Peking University First Hospital, Chief Physician, Doctoral Supervisor, and Postdoctoral Cooperative Supervisor. He serves as Deputy Director of the Institute of Urology at Peking University, Deputy Director of the Tumor Translational Center at Peking University First Hospital, and Director of the Research Office at Peking University First Hospital. He has long been dedicated to the research on the diagnosis, prevention, and treatment of rare and difficult urogenital system tumors, and has presided over more than 20 projects including major projects of the Ministry of Science and Technology, key projects and general programs of the National Natural Science Foundation, and the Beijing Natural Science Foundation.
Professional Roles
Currently serves as a member of the "National High-level Talent Special Support Program (Ten Thousand Talents Program of the Central Organization Department)", a "Young and Mid-aged Leading Talent in Scientific and Technological Innovation" of the Ministry of Science and Technology, a "New Century Excellent Talent" of the Ministry of Education, a member of the first committee of the Rare Disease Branch of the Chinese Medical Association, chairman of the Rare and Difficult Diseases Alliance of Urology of the Chinese Medical Association, member of the Oncology Group of the Urology Branch of the Chinese Medical Association, deputy leader of the Translational Science Group of the Urology Branch of the Chinese Medical Association, vice chairman of the Urology Branch of the China Medical Promotion Association, member of the Urologic Oncology Committee of the Chinese Medical Doctor Association, executive director of the Rare Disease Branch of the Chinese Research Hospital Association, advisory member of the International VHL Alliance (the only one in China), and editorial board member of the "Chinese Urological Disease Diagnosis and Treatment Guidelines - Prostate Cancer".